II. Indication
- Chlamydia screening in symptomatic and asymptomatic patients
III. Background
- Chlamydia Antigen testing has replaced Chlamydia culture
- Nucleic Acid Amplification Tests (NAAT, PCR) are the primary tests used in the U.S. for Chlamydia detection
IV. Precautions
- Avoid rapid point-of-care Chlamydia tests (very low accuracy, see below)
V. Labs
VI. Technique
- General
- Eye Sample
- Topical Eye Anesthetic applied
- Swab lower and upper lids (inner surface)
- Urethral Samples (Males)
- Cervical Samples
- Vaginal Sample
- Vaginal swabs have similar accuracy to endocervical swabs
- In contrast, Pap SmearNAAT liquid cytology has lower Test Sensitivity than endocervical and vaginal samples
- Rectal Samples (symptomatic patients)
- Insert Dacron swab 3 cm into anal canal
- Withdraw swab
- Fecal contaminated samples should be redone
- Urine Sample
- Obtain first catch, "dirty" urine without applying antiseptic before voiding
- May miss up to 10% of Cervicitis cases (compared with endocervical swabs)
VII. Efficacy
- Chlamydia Nucleic Acid Amplification Tests (NAAT, PCR)
-
Chlamydia DFA, EIA (older methods, replaced by PCR)
- Test Sensitivity: 88-91%
- Test Specificity: 97-99%
- Chlamydia Rapid Point-Of-Care Tests (avoid, very high False Negative Rate)